SCHEMBL9857294

SCHEMBL9857294

CNCCC(Cc1ccc(C)cc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.53
HRH1 P35367 5/20 0.53
SLC6A4 P31645 9/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SLC6A2 P23975 7/20 0.43
CYP3A4 P08684 5/20 0.43
CYP2D6 P10635 5/20 0.43
SLC6A3 Q01959 5/20 0.43
CYP1A2 P05177 4/20 0.43
KCNH2 Q12809 4/20 0.43
ADRA2B P18089 3/20 0.43
OPRM1 P35372 3/20 0.43
DRD3 P35462 3/20 0.43
OPRK1 P41145 3/20 0.43
TSHR P16473 3/20 0.43
KMT2A Q03164 3/20 0.43
CHRM1 P11229 2/20 0.43
HTR2C P28335 2/20 0.43
HTR2B P41595 2/20 0.43
KLF10 Q13118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8384207 0.90 HTR2A (0.60) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9857112 0.87 HTR2A (0.53) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9856505 0.87 HTR2A (0.53) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9856936 0.86 SLC6A4 (0.55) HTR2AHRH1SLC6A4SLC6A2CYP2D6
SCHEMBL9856731 0.86 SLC6A4 (0.55) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9856456 0.84 HTR2A (0.50) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9856612 0.83 ALDH1A1 (0.61) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9856914 0.83 HTR2A (0.49) HTR2AHRH1SLC6A4SMN1; SMN2SLC6A2
SCHEMBL9856887 0.83 HTR2A (0.49) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9856532 0.82 SLC6A4 (0.58) HTR2AHRH1SLC6A4SMN1; SMN2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed